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Former researches showed ginger extracts could contribute to hepatic protection.  
 
Two species of cytochrome P450 enzymes, CYP2E1 and CYP2A6, are both important  
 
heme-containing liver enzymes for hepatictoxicology via metabolizing small organic  
 
molecules into toxic metabolites. CYP2E1 metabolizes more than 2% of all the oral drugs  
 
and is closely associated with liver toxicity. CYP2A6 metabolizes fewer than 5% of all  
 
the oral drugs and activates some tobacco procarcinogens. Therefore, inhibitors from  
 
natural extracts might be able to provide with preventative therapy to liver toxicity and  
 
cancer. CYP2E1 inhibitors may be used to inhibit liver toxicity of CYP2E1 in  
 
metabolizing the pain killer acetaminophen into toxic N-acetyl-p-quinoimine (NAPQI) to  
 
prevent liver cell necrosis. In addition, CYP2A6 inhibitors may be used to suppress the  
 
metabolism of certain pro-carcinogens that are inhaled from smoking. 
 
In this research, two extracts from steam distillation of ginger root, ginger  
 
essential oil and ginger hydrosol, were collected. CYP2E1 and CYP2A6 were assayed  
 
with presence of the two extracts at a series of concentrations to test the ginger extracts’  
 
dose-dependent effects. The results showed both of the two extracts as CYP2E1  
 
inhibitors but as poor inhibitors to CYP2A6. The major organic contents of ginger  
 
essential oil and ginger hydrosol were identified by GC-MS. The results showed both of  
 
them contained citral. The major organic components of ginger hydrosol were  
 
determined as citral (neral and geranial), 2-heptanol and eucalyptol.  
 
The Michaelis-Menten kinetic analysis showed that ginger essential oil, citral 
 
and ginger hydrosol were all competitive inhibitors to CYP2E1 from human liver S9  
 
fraction. The KI for Brazilian ginger essential oil was 27.3mg/L and the KI for Costa  
 
Rican ginger essential oil was 29.9 mg/L. The inhibitory constant of citral was KI of  
 
43.0μM. Meanwhile, the KI for Brazilian ginger hydrosol was 4.6% of its original  
 
concentration, which corresponded to 45.5 µM citral (neral: geranial=1:1.4).The KI for  
 
the Brazilian ginger hydrosol was 3.6% of its original concentration, which corresponded  
 
to 44.3µM citral (neral: geranial=1:1.4). Citral was implicated to be the most potent  
 
inhibitor from ginger hydrosol to human liver CYP2E1. 
 
Ginger hydrosol and citral were shown to be inhibitors to purified human liver  
 
CYP2E1 in the metabolism of acetaminophen to NAPQI by analysis with LC-MS. In the  
 
presence of the substrate acetaminophen at 800μM, the concentration close to its toxic  
 
concentration, Brazilian ginger hydrosol exhibited a 50% inhibition of enzyme activity at  
 
the concentration over 25%. This concentration of Brazilian ginger hydrosol corresponds  
 
to a dose of citral of around 158 μM. This result implicated that ginger hydrosol and citral  
 
could be used as a natural therapeutic for toxicity of acetaminophen.
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CHAPTER I 
 
INTRODUCTION 
 
 
I. A. Liver Protection Functions of Ginger Extracts 
 
Ginger (Zingiber officinale) is a flowering plant of which the rhizome was  
 
traditionally used as a spicy food and herb for therapy. Extracts from ginger showed  
 
anti-inflammation properties via the inhibition of cyclooxygenase-2 (COX-II) [1]. The  
 
aqueous extract of ginger rhizome was shown to protect against inducted toxicity of  
 
acetaminophen by suppressing the acetaminophen induced reduction of enzymes like  
 
glutathione peroxidase or glutathione-S-transferase and thus increase the overall  
 
antioxidant levels [2]. Therefore, it is able to inhibit the generation of oxidative stress  
 
markers such as lipid peroxidation, which can result in destruction in the plasma  
 
membrane and apoptosis. The ginger rhizome extract was reported to inhibit cellular  
 
toxicity via enhancing the body’s levels of glutathione (GSH), a cellular antioxidant.  
 
GSH can conjugate with and neutralize N-acetyl-p-benzoquinone imine, which is formed  
 
by metabolism of acetaminophen by certain cytochrome P450 enzyme [2]. 
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I. B. Cytochrome P450 Enzymes  
 
The cytochrome P 450 proteins, i.e. CYP 450, are phase I monooxygenases found  
 
in diverse organisms that catalyze mono-oxidation of endogenous and xenobiotic  
 
compounds [3]. The cytochrome P450 enzymes were at first named for their significant  
 
absorbance at 450 nm in complex with carbon monoxide [4][5][6]. Their active site  
 
contains a ferric iron (Fe
3+
) heme group as shown by Figure 1. 1 in which the central iron  
 
coordinates with four nitrogen atoms in the heme plane. A cysteine residue in the bottom  
 
axial position attaches the heme to the enzyme via its thiol group’s sulfur [7]. In the  
 
non-activated form, this Fe
3+ 
also coordinates with a water molecule’s oxygen at the top  
 
axial position as shown by Figure 1. 2. 
 
 
 
Figure 1. 1. The Iron Heme Group of the Active Site of P450. 
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Figure 1. 2. Simplified Heme Group at the Active Site of P450.The ferric iron (Fe
3+
) is coordinated by 
four nitrogen atoms in the heme plane and one water molecule’s oxygen in the top axial position and one 
enzyme cysteine residue’s thiol sulfur in the bottom axial position. The Fe
3+ 
also coordinates with a water 
molecule’s oxygen to the top axial position. 
 
 
In order to become catalytically active, this heme group needs to be activated by 
molecular oxygen [8].This whole process was shown by Figure 1. 3. Once activated, this  
active site heme group is able to catalyze various monooxygenation reactions such  
as alkane hydroxylation, alkene epoxidization, aromatic epoxidation, dealkylation, etc.  
Such catalyzed reactions contribute to metabolism of the majority of drugs and  
zenobiotics and endogenous metabolites [8] [9][10]. 
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Figure 1. 3. Activation of the Heme Group of CYP450 by Molecular Oxygen. (A): Redox potential 
enhancement of the ferric iron induced by substrate binding; (B): Nicotinamide coenzyme and flavin 
coenzyme aided reduction of ferric iron into ferrous iron, i.e. Fe
2+
;(C) (D) (E) (F): Molecular oxygen 
binding and heme peroxide formation; (G) (H): O-O bound break and formation of highly-oxidative 
Fe
5+
oxoferrylheme.
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I. C. Cytochrome P450 2E1 
Cytochrome P450 2E1 (CYP2E1) is an isoform of the cytochrome P450 super 
family. Compared to other CYP450 enzymes, CYP2E1 has a relatively small active site 
which was shown to be around 182 cubic Å [11] as shown in Figure 1. 4. Restricted by 
the small size of the active sites, the compounds that can be metabolized by CYP2E1are 
mainly small molecules. These small molecules are mainly metabolized by hydroxylation, 
which increases their solubility and thus facilitates their excretion [12].Toxic metabolites 
can be produced by metabolism by CYP2E1 of certain small organic compounds such as 
toluene [13], halothane, chloroform, pyridine [14], pyrazole [15], acetone, ethanol [16] 
[17], and acetaminophen [18].Human liver CYP2E1 metabolizes more than 2% of all the 
oral drug and is closely associated with liver toxicity. Long exposure to CYP2E1 inducers 
was also implicated to be associated with an increased risk of liver malignancy [19]. The 
hydroxylation of 4-nitrophenol (PNP) into 4-nitrocatechol shown in Figure 1. 5 was used 
to assay the activity of CYP2E1. Prior researches implicated that when the total 
concentration of CYP450 in one reaction was lower than 50μM, the major 4-nitrophenol 
hydroxylase was CYP2E1. The reaction of hydroxylation of 4-nitrophenol would thus be 
eligible to be used to assess the activity of CYP2E1. 
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Figure 1. 4. Active Site of Human CYP2E1. The volumes were calculated by online tool Q-Site Finder in 
the research of Li et al based on Protein Data Bank Code 3e4e [11].  
 
 
 
 
 
 
 
 
 
Figure 1. 5. Hydroxylation of 4-Nitrophenol (PNP) into 4-Nitrocatechol Catalyzed by CYP2E1. 
 
 
I. D. Cytochrome P450 2A6 
 
CYP2A6 was shown to metabolize fewer than 5% of all drugs and catalyzes the  
activation of certain procarcinogens [20]. Cytochrome P450 2A6 (CYP2A6) metabolizes  
some tobacco carcinogens and its activity has been associated with development of lung  
cancer [21]. The hydroxylation of coumarin into 7-hydroxycoumarin shown in Figure 1.6  
was recorded as an exclusive reaction catalyzed by CYP2A6 [22] and thus was used to  
assay the activity of CYP2A6. 
Catalysis of CYP2E1 
NADPH 
NADP
+
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Figure 1. 6. Hydroxylation of Coumarin in 7-Hydroxycoumarin Catalyzed by CYP2A6. 
 
 
I. E. Ginger Essential Oil and Hydrosol 
 
In order to obtain extracts containing relatively small compounds as inhibitors for  
 
CYP2E1 and CYP2A6, extracts from distillation were selected as candidates. Such  
 
extracts include ginger essential oil and ginger hydrosol. By definition, essential oil is the  
 
oil collected from parts of the plant species by distillation. Hydrosol is the fragrant water  
 
formed as a byproduct from the steam distillation in essential oil production. Its name  
 
comes from a combination where “hydro” means water and “sol” means solution [23]. By  
 
property, it is a water solution where some water soluble microdrops of the essential oil  
 
and some water soluble volatile components of the plant coexist. The essential oil and  
 
hydrosol are separate by their differences in gravity. Therefore, in the distillation  
 
operation the essential oil would always be collected from the upper layer of the collector  
 
vessel because it is heavier than hydrosol which needs to be collected from the lower  
 
layer. [23] Both the essential oil and hydrosol of ginger possess soothing, anti- 
 
inflammatory or antiseptic properties [23][24].  
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I. F. Importance of Searching for CYP2E1 and CYP2A6 Inhibitors from Ginger  
 
Extracts  
 
The aqueous extract of ginger rhizome was shown to protect against inducted  
 
toxicity of acetaminophen by suppressing the acetaminophen induced reduction of  
 
enzymes like glutathione peroxidase or glutathione-S-transferase. In other words, it  
 
increased the overall antioxidant levels [2], preventing the occurrence of oxidative stress  
 
markers such as lipid peroxidation or destruction of the plasma membrane, which leads to  
 
apoptosis. Meanwhile, the ginger rhizome extract was also reported to inhibit cellular  
 
toxicity via enhancing the body’s levels of glutathione (GSH), a cellular antioxidant that  
 
binds to one apoptosis-inducing metabolite of acetaminophen [2]. 
 
As for the physiological benefit from ginger extract via restriction of toxicity,  
 
although prior studies showed the aqueous extract of ginger rhizome could protect against  
 
toxicity of acetaminophen by suppressing the acetaminophen induced reduction of  
 
antioxidant enzymes [2], there are still few reports on whether ginger extracts could  
 
directly inhibit CYP 2E1 catalyzed generation of liver-toxic metabolism, such as  
 
metabolism of acetaminophen into N-aceto-p-benzoquinoimine (NAPQI). 
 
Meanwhile, since the size of CYP2A6 active site is relatively small as shown by 
 
Figure 1. 7 [25], we looked for possible CYP2A6 inhibitors from the distillation extracts 
 
made from ginger rhizomes. (The molecular sizes of most of the components from the  
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ginger distillation extracts are small.) Searching for the possible CYP2A6 inhibitor from 
  
ginger extracts from steam distillation could help evaluate such extracts’ potency as a  
 
natural therapeutic in preventing malignancy resulting from smoking. 
 
 
 
 
Figure 1. 7. Active Site of CYP2A6 Showing the Heme in Complex with Nicotine. The dimensions were 
shown in Å. 
 
 
I. G. Research Method Outline  
 
This research started from making steam distillation extracts from ginger. Two types  
 
of extracts were obtained from distillation: ginger essential oil and ginger hydrosol. Dose  
 
dependent effects of these extracts were carried out to CYP2E1 and CYP2A6 using the  
 
protocols described in prior studies to test whether and how much they inhibited these  
 
two cytochrome P450 enzymes [26]. Then the component analysis of ginger essential oil  
 
was directly done with GC-MS; the component analysis of ginger hydrosol was done  
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with a method combining HPLC with GC-MS. New dose response tests of human liver 
  
CYP2E1 were done with certain pure compounds that constituted the components of  
 
ginger essential oil and hydrosol. Further tests were performed to assess the potential of  
 
ginger hydrosol in inhibiting the metabolism of acetaminophen into  
 
N-aceto-p-benzoquinoimine (NAPQI) by human liver CYP2E1 (Figure 1. 8). Since  
 
NAPQI is an unstable compound, its quantification could not be performed before it was  
 
converted to a relatively stable complex. This purpose was achieved by conjugating  
 
NAPQI with reduced glutathione (GSH) into NAPQI-GSH conjugate. This reaction was  
 
catalyzed by glutathione-S-transferase (provided by human liver cytosol) via conjugating 
 
NAPQI with GSH (Figure 1. 9). The GSH was added at high concentration in order to  
 
convert all of the NAPQI formed into conjugate in order to evaluate the CYP2E1 activity 
 
accurately [22]. 
 
This research would finally show whether compounds from ginger could be possible  
 
protector of the liver by direct inhibition of metabolic generation of toxic metabolites. 
 
The further research of the candidate CYP2E1 inhibitory chemicals could also assess 
 
their effect in protection of liver cells against toxicity from acetaminophen metabolism.  
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Figure 1. 8. Metabolism of Acetaminophen into NAPQI Catalyzed by CYP2E1. Acetaminophen is at 
first be hydroxylated by CYP2E1. Then this hydroxylated intermediate formed would lose one molecule of 
water to form NAPQI. 
 
 
 
 
Figure 1. 9. Conjugation of NAPQI with GSH Catalyzed by Glutathione-S-Transferase.  
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CHAPTER II 
 
EXPERIMENTS 
 
 
II. A. Source of Purchased Materials 
The 4-nitrophenol was purchased from Sigma-Aldrich, St Louis, MO, USA. The 
4-nitrocatechol was purchased from Acros Organics, New Jersey, USA. The monobasic 
and dibasic potassium phosphates were purchased from Carolina Biology Supply 
Company, Burlington, North Carolina, USA.The reduced NADPH was purchased from 
Chem-Impex Int. Inc, Wood Dale, Illinois, USA. The 95% citral standard was purchased 
from Sigma-Aldrich, St Louis, MO, USA. The 98% reduced L-glutathione was purchased 
from Sigma-Aldrich, St Lois, MO, USA.The 98% 4-acetominophenol was purchased 
from Acros Organics, New Jersey, USA.The 99% eucalyptol was provided by Alfa Aesar, 
Ward Hill, Massachusetts, USA. The 99% coumarin was provided by Acros Organics, 
New Jersey, USA.  
The rabbit liver cytochrome was prepared from frozen rabbit liver provided by Pel 
Freez Biological Inc, Arkansas, USA. The human liver cytochrome S9 fraction was from 
Sigma-Aldrich, St Louis, MO, USA. The purified human liver 2E1 enzyme was from 
Xeno Tech, Lenexa, KS, USA. The Human Liver Cytosol (Mixed Gender) was purchased 
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from Xeno Tech, Lenexa, KS, USA. The ginger rhizomes were originally grown and  
harvested in Costa Rican and Brazil. They were purchased from local markets in 
Greensboro, NC, USA. 
II. A. i. Preparation of Ginger Extracts: Essential Oil and Hydrosol 
The ginger rhizomes were processed in order to be ready for performing extraction 
by distillation. The ginger rhizomes were cleaned, peeled and sliced into uniform blocks 
with diameter of about 2mm. Then the ginger root blocks would be delivered into the flask 
of the formerly set up hydro-distillation equipment (Figure 2. 1) in a mass-volume 
proportion of 500g ginger root blocks / 1500mL DI water and distillated with DI water at 
100 ˚C at 1atm for around 5 hours. The essential oil was collected from the oil phase in the 
upper layer of liquid in the collector and the hydrosol was from the water phase in the 
lower layer. The collected oil phase was centrifuged at 14000rpm for 10min to remove the 
attached water. Both of the essential oil and hydrosol were stored at -80 ˚C.  
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Figure 2. 1. Apparatus of Steam Distillation for Ginger Extract Production. The ginger essential oil 
was collected from the upper layer in the collector and the ginger hydrosol was collected from the lower 
layer in the collector. 
 
 
II. B. Dose Response Tests of CYP 2E1 and CYP2A6 with Ginger Extracts 
 
Dose responses tests of CYP2E1 and CYP2A6 were carried out with addition of  
 
ginger essential oil and hydrosol to assay the enzymes’ activity changes and thus the  
 
inhibitory potencies of the two ginger extracts. 
 
II. B. i.  Dose Response Tests of CYP2E1 with Ginger Essential Oil and  
 
       Hydrosol 
 
The enzyme sources used in the dose response tests for CYP2E1 were liver S9 
 
fraction from rabbit liver (Pel Freez Biological Inc, Arkansas, USA) and human liver  
 
Ginger Essential Oil from 
the Upper  
Layer Oil Phase  
 
Ginger Hydrosol, from the 
Lower  
Layer Water Phase  
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(Molecular Toxicology Inc.). The total volume of each reaction mixture was 200µL. The  
 
final concentration of CYP450 from rabbit liver was 40 nM and the final concentration of  
 
CYP450 from human liver was 33 nM. The buffer used in this assay was potassium  
 
phosphate buffer with a pH of 7.0 and a final concentration of 0.1Mfor each reaction. The  
 
substrate was 4-nitrophenolwith a dose of 60 µM for assays of rabbit liver CYP2E1 and 70  
 
µM for assays of human liver CYP2E1.For the dose response test of ginger extracts, the  
 
ginger essential oil was added at doses of 6mg/L, 12mg/L, 18mg/L and 24mg/L and the  
 
ginger hydrosol was added in a in a volume percentage series of 12.5%, 25%, 37.5%, 50%  
 
in the reaction mixtures. After 8 minutes of pre-incubation at 37˚C, NADPH was added to  
 
initiate the reaction with a final concentration of 1.0mM. The reactions were incubated  
 
at37˚C for 45 minutes beforebeing quenched by 200µL 7% perchloric acid. Then each tube  
 
of mixture was be centrifuged at 14,000 rpm for 10 min and the supernatants were run on  
 
HPLC (Shimazu LC-20AT) to analyze the catalytic activity of human & rabbit liver  
 
CYP2E1. This analysis was carried out by monitoring the area of the optical density signal  
 
of the product 4-nitrocatechol at the wavelength of 340 nm (Figure 2. 2). The results are  
 
expressed as average percentage of enzyme activities± average percentage of standard  
 
deviations. To do this analysis, a C-18 column (4.6×150 mm) was used with a mobile  
 
phase of H2O/ acetonitrile/ trifluoroacetate (70/ 30/ 0.1 v/ v/ v) at a flow rate of 1.000 mL 
 
/min. The absorption wavelength for analysis was selected at 340 nm and the product peak  
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of 4-nitrocatecol was eluted at about 5.2 min. The peaks of the product were integrated and  
 
the dose response of the ginger hydrosol was measured as percent decrease of the product  
 
peaks with standard deviations.  
 
 
 
 
Figure 2. 2.The HPLC Chromatogram of the CYP 2E1 Assay. The chromatogram was obtained by the 
UV detector under the wavelength of 340nm.The product peak of 4-nitrocatecol was eluted at about 5.2 min. 
 
 
 II. B. ii.  Dose Response Tests of CYP2A6 with Ginger Essential Oil and  
  Hydrosol 
 
The enzyme sources used in the dose response assays for CYP2A6 were S9  
 
fraction from rabbit liver (Pel Freez Biological Inc, Arkansas, USA).Each reaction  
 
mixture was 200µL within which the concentration of CYP450 from rabbit liver was  
 
40 nM and the CYP450 for human liver S9 fraction was 33 nM. The buffer that was used  
 
in this assay was also potassium phosphate buffer with pH of 7.0 and a final  
4-nitrocatechol 
4-nitrophenol 
NADPH 
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concentration of 0.1M in each reaction mixture. The substrate used in the 2A6 assays was  
 
coumarin (1, 2-benzopyrone) with a final dose of 3µM each. For the dose response test of  
 
ginger extracts, the ginger essential oil was added at doses of 6mg/L, 12mg/L, 18mg/L  
 
and 24mg/L and the ginger hydrosol was added in a in a volume percentage series of  
 
12.5%, 25%, 37.5%, 50% in the reaction mixtures. After 8 minutes of pre-incubation at  
 
37˚C, NADPH was added to initiate the reaction with a final concentration of 1.0mM.  
 
The reactions were incubated at 37˚C for 30 minutes and quenched by 20 µL 70%  
 
perchloric acid. Then each tube of mixture was centrifuged at 14,000 rpm for 10 min and  
 
the supernatants were run on HPLC (Shimazu LC-20AT) to analyze the catalytic activity  
 
of human & rabbit liver CYP2A6.This analysis was carried out by monitoring the area of  
 
the optical density signal of the product of 7-hydroxycoumarin at the wavelength of 320  
 
nm.The results are expressed as average percentage of enzyme activities± average  
 
percentage of standard deviations. To do this analysis, a C-18 column (4.6×150 mm) was  
 
used with a mobile phase of H2O/ acetonitrile/ trifluoroacetate (70/ 30/ 0.1 v/ v/ v) at a  
 
flow rate of 1.000 mL / min. The absorption wavelength for analysis was selected at 320  
 
nm and the product peak of 7-hydroxycoumarin was eluted at about 3.1 min as shown in  
 
Figure 2. 3. The peaks of the product were integrated and the dose response of the ginger  
 
hydrosol was measured as percent decrease of the product peaks with standard  
 
deviations. 
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Figure 2. 3. The HPLC Chromatogram of the CYP 2A6 Assay. The chromatogram was obtained by the 
UV detector under the wavelength of 320nm.The product peak of 7-hydroxycoumarin was eluted at about 
3.1 min. 
 
 
II. C. Component Analysis of Ginger Extracts: Essential Oil and Hydrosol 
 
The component analysis of the two ginger extracts, i. e. ginger essential oil and  
 
ginger hydrosol were performed in order to identify the possible inhibitors to CYP2E1  
 
and CYP2A6.  
 
 
 
 
7-Hydroxycoumarin 
Coumarin 
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 II. C. i. Content Analysis of Ginger Essential Oils 
 
The ginger essential oils from Brazilian ginger and Costa Rican Ginger were  
 
directly analyzed by GC mass spectrometer. For the GC mass spectrometry, the organic  
 
solvent used was hexane. Each oil sample was added with 5 µL in 200 µL of hexane  
 
before being run on GC-MS. The total elution time was 10.0 min. 
 
 II. C. ii. Component Analysis of Ginger Hydrosols 
 
The organic components dissolved in the water phase of ginger hydrosol were  
 
trapped onto the C18 column (4.8×150 mm, Shimazu) with a mobile phase consisted of  
 
close to 100% DI water and 0.1%TFA by injecting 1500µL hydrosol in the HPLC. The  
 
trapped components were eluted with a mobile phase of 100% methanol and the eluted  
 
solution were analyzed by GC-MS (Shimazu SSI GCMS-QP2010S). 
 
II. D. Dose Response Tests of CYP2E1 with Major Components from Ginger  
Hydrosol 
 After the major components of ginger hydrosol were determined, dose response 
tests were done in order to find the major components as the major inhibitors to the 
CYP2E1. The dose response tests started from assays with rabbit liver CYP2E1. Once a 
dose response was found to be attributed to a certain component, it would be tested in an 
assay with human liver CYP2E1. The setup for the dose response tests of CYP2E1 with 
components of ginger extracts was the same as for the assays done for testing the dose 
responses of CYP2E1 with ginger extracts. Because small chain alcohols were already  
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determined not to inhibit CYP2E1 by early projects of our group, no dose dependent  
assay was done of CYP2E1 with 2-heptanol. The dose response tests were only carried out 
with eucalyptol and citral. The major components of ginger hydrosol determined in this 
research were shown in Figure 2. 4. 
 
 
 
 
 
 
 
   A.                     B. 
                         
       C.                      D. 
 
Figure 2. 4. Four Major Components of Ginger Hydrosol that Were Determined. A. B: Citral; A: 
(Z)-3.7-Dimethyl-2,6-octadienal (neral); B:E)-3,7-Dimethyl-2,6-octadienal (Geranial) C: Eucalyptol; D: 
2-Heptanol. 
 
 
For the dose response test of eucalyptol, the eucalyptol (Alfa Aesar,Ward Hill,  
 
Massachusetts, USA) was added at doses of 115.2 µM, 230.4µM, 460.8µMin the reaction  
 
mixtures. The reactions after incubation were analyzed by HPLC (ShimazuLC-20AT)  
 
under the same conditions as the assays for the dose response tests of CYP2E1 with  
 
ginger extracts. 
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 For the dose response test of citral, the citral standard was 95% in purity with an  
 
isomer ratio of neral: geranial=1:1.8 (Acros Organics, New Jersey, USA). It was added at  
 
doses of 0, 112 µM, 245µM, 489µMin the reaction mixtures. The reactions after incubation  
 
were analyzed by HPLC (ShimazuLC-20AT) under the same conditions as the assays for  
 
the dose response tests of CYP2E1 with ginger extracts. 
 
II. E. Standardization of Citral in Ginger Extracts 
 
Standardization of citral concentrations in ginger extracts were carried out in order  
 
to know the concentrations of citral in each ginger extract. The ginger extracts, i.e. the  
 
Brazilian and Costa Rican ginger essential oil aqueous solution and hydrosol were run on  
 
HPLC (Shimazu LC-20AT) with a C18 column (Waters, 4.6 ×250mm) with a flow rate of  
 
1.0mL/min and a mobile phase of 50% acetonitrile + 50% DI water + 0.1% TFA. The  
 
absorption wavelength was set as λ=260 nm. The two peaks of neral and geranial were  
 
eluted at 8.5 to 9.2 min and 9.2 to 9.9 min (Figure 2. 5). The first eluted peak was for  
 
neral and the second was for geranial, referring to the method of Sacks et al [27]. The  
 
concentrations of citral in the four ginger extracts were standardized with citral standard  
 
solutions. 
 
 
22 
 
 
 
Figure 2. 5. HPLC Chromatogram of Netral and Geranial in Ginger Extracts. The ratio of the peak 
areas of neral geranial for the ginger extracts were calculated as the isomer ratio (neral to geranial) of all 
the ginger extracts. 
 
 
II. F. Preparation of Standard Citral Solution with Desired Isomer Ratio 
 
Standard citral solutions with a neral to geranial ratio close to 1:1.4 of ginger  
 
hydrosol should be made to assess the Michaelis-Menten kinetics of citral as a  
 
component from ginger hydrosol on human liver CYP2E1. Standard solution of citral  
 
with such an isomer ratio was obtained by isolation on HPLC (Shimazu LC20-AT) with a  
 
semi-prep column (HS-1010-M185). To prevent from disturbance of residue organic  
 
mobile phase on CYP2E1 in the assays, the dose response tests of an organic mobile  
 
Geranial  
Neral 
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phase on human liver CYP2E1 were done to select one with an adequately low inhibition.  
 
Methanol and acetonitrile were tested in dose response assays with the same conditions 
  
as assays for dose response tests for ginger extracts. The only difference was that the  
 
acetonitrile was added at volume doses at 0.5%, 1% and 2% where as the methanol was  
 
added at 0.1%, 0.2%, 0.5% and 1%. The one with an adequately low inhibition on  
 
CYP2E1 was selected as the mobile phase for the preparation of citral with the desired  
 
isomer ratio. At the beginning of citral isolation, 20µL crude citral with a 95% purity  
 
(provided by Sigma-Aldrich) was trapped onto the semi-prep column with a mobile phase  
 
composed of 100% DI water and 0.1% TFA. Then the citral component were eluted by  
 
another TFA-free mobile phase of 90% DI water + 10% acetonitrile. Solutions with  
 
predominantly neral & geranial were obtained by collecting the HPLC elutes when the  
 
earlier and later parts of the peaks of citral showed up. The citral standard solution with  
 
neral to geranial ratio of 1:1.27 and 1:1.45 were obtained by mixing the solutions of neral  
 
and geranial to calculated volumetric proportions. These citral solutions were stored at – 
 
80˚C. 
 
II. G. Michaelis-Menten Kinetic Analysis of Human Liver CYP2E1 with Citral or  
 
Ginger Extracts 
 
After the dose responses of CYP2E1 to ginger extracts and isolated components of  
 
ginger extracts were tested, the Michaelis-Menten kinetic analysis of the ginger extracts  
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and the CYP2E1 inhibitory component(s) were carried out to determine their inhibitory  
 
kinetics. For the reaction mixtures the dose of enzymes (rabbit liver CYP2E1 and human 
  
liver CYP2E1), NADPH, buffer were set to be the same concentrations as that of the dose  
 
response assay of CYP2E1. The volume for each reaction mixture was still 200 µL and the  
 
time for incubation was still 45 min. Each reaction was carried out in triplicates. For the  
 
same curve of trial with inhibitor, the same dose of ginger extract was used for all the  
 
reactions. The citral used as inhibitor for human liver CYP2E1 and purified human liver  
 
2E1 had an isomer ratio of neral : geranial =1:1.27. The concentrations of the substrate  
 
PNP in each incubation tube were set at 30µM, 60 µM, 120 µM, 240 µM, 480µM for the  
 
kinetic analysis with ginger extracts and were 15µM, 30µM, 60 µM, 120 µM, 240 µM for  
 
analysis with citral. The ginger extracts tested were the essential oil solution and hydrosol  
 
from both Costa Rican and Brazilian ginger roots. The Michaelis-Menten curves were  
 
generated with the software of Slide Write and the Vmax and KM were calculated. The types  
 
of inhibition, i.e. competitive/ un-competitive/ non-competitive were analyzed and the  
 
inhibitory constants of KI for competitive inhibition and KI’ for non-competitive inhibition  
 
were calculated with the equations of KI=[I]*KM/(KM
app
-KM)  
 
andKI’=[I]*Vmax
app
/(Vmax-Vmax
app
). 
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II. H. Assessment of Inhibition of Human Liver CYP2E1 by Ginger Hydrosol in  
 
Acetaminophen Metabolism 
 
Assays were designed and carried out to assess the potency of ginger hydrosol in 
 
the inhibition of the metabolism of acetaminophen by human liver CYP2E1. It started  
 
with synthesis of NAPQI-glutathione (NAPQI-GSH) via organic synthetic method to  
 
provide with the standard for analysis. Catalytic formation of NAPQI-GSH complex were  
 
set up with purified human liver CYP2E1 and GSH reductase from human liver cytosol  
 
and the identification of NAPQI-GSH were carried out with UPLC-MS. Finally, the dose  
 
response tests of citral in metabolism of acetaminophen by human liver CYP2E1 were  
 
carried out with the reaction of NAPQI-GSH’s formation with presence of ginger  
 
hydrosol.  
 
 II. H. i. Synthesis of NAPQI-Glutathione Complex Standard 
 
The method for synthesizing NAPQI-glutathione complex was described by Rousar  
 
T et al [28]. It consisted of the following steps. 
 
Silver nitrate (4.224g ) was dissolved in 65 mL DI water. 8g sodium hydroxide was 
 
dissolved in 250mL DI water. Silver oxide was generated by mixing both of the solutions  
 
above. Then the silveroxide formed was filtered by glass sinter glass funnel with  
 
vacuum,rinsed and stored. 
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4-Acetominophenol (Figure 2. 6) 0.428g was dissolved in chloroform dried with  
 
nitrogen gas. The newly made silver oxide was added in the chloroform solution of  
 
4-nitrophenol and the mixture was stirred for 1 hour to generate NAPQI (Figure 2. 7).  
 
The mixture was filtered and the yellow chloroform solution containing NAPQI was  
 
stored. 
 
 
 
 
Figure 2. 6. Formula of 4-Acetaminophen: N-Acetyl-p-aminophenol (APAP). 
 
 
 
 
Figure 2. 7. Formula of N-Acetyl-p-Benzoquinone Imine (NAPQI). 
 
 
Reduced glutathione was dissolved in 250 mL 0.1M sodium phosphate buffer with  
 
a pH of 7.4. The chloroform solution of NAPQI was added drop-wise in the glutathione  
 
solution while the glutathione solution was stirred to allow glutathione to conjugate with  
 
NAPQI. The water phase containing the complex was isolated by a separatory funnel.  
 
The water was evaporated with a rotary vacuum evaporator (Heidolph Instruments,  
 
Leiden, Netherlands) at 40˚C at the pressure of 1mbar, 300rpm, and the resultant residue  
 
was stirred with 700mL methanol. The resultant liquid was filtered with glass sinter  
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funnel to remove the remaining solid which was stored as the first part of residue for 
 
detection of the target product, NAPQI-GSH conjugate. The clear methanol solution was  
 
collected for vacuum evaporation on a rotary evaporator (Heidolph Labolutions, Leiden,  
 
Netherlands) at the pressure of 1mbar, 300rpm to get rid of the majority of methanol.  
 
Further drying with nitrogen gas was done on the residue to remove the rest of methanol.  
 
The solid residue left from this step was also stored for detection of NAPQI-GSH  
 
complex (Figure 2. 8). 
 
 
 
 
Figure 2. 8. Formula of NAPQI-GSH Complex. 
 
 
The two parts of residues from the NAPQI-GSH generation step were both  
 
replenished with DI water to make their own stock solutions with the same mass  
 
concentration of 15g/ L. Both of these solutions were analyzed by the UPLC-MS (UPLC:  
 
Waters “Acuity Ultra Performance LC” with Waters C18 Column of 3.6×50mm; MS:  
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Thermo TSQ Quantum Access – Triple Stage Quadruple Mass Spectrometer) to identify  
 
the one in which the NAPQI-GSH was the most abundant.  For the UPLC, the mobile  
 
phase was 5% acetonitrile + 95% DI water + 0.1% acetic acid and the flow rate was  
 
0.3mL/min. The total run time was 10 min. The sample temperature was 10˚C and the  
 
column temperature was 40 ˚C. The ionization mode for the mass spectrometer was  
 
positive mode and the target molecules of NAPQI-GSH were protonated into ions with  
 
the mass of about 457.14 amu. The chromatograms for the protonated NAPQI-GSH were  
 
set to be expressed in the selected ions with the mass of 457.14 amu. 
 
II. H. ii. Isolation of Standard NAPQI-GSH Complex from the Stock 
 
 After identifying the solid residue of which the aqueous solution contained the  
 
higher concentration of NAPQI-GSH complex at the mass concentration of 15g/ L, the  
 
solution of this residue was separated into five eluted fractions corresponding to the  
 
observed five isolated peaks by HPLC (Shimazu LC-20AT). These five fractions were  
 
analyzed to determine the fraction with the highest concentration of NAPQI-GSH 
  
complex and such a fraction would be used as the standard of NAPQI-GSH. The HPLC  
 
(Shimazu LC-20A, column: C18-4.6×250mm, Waters) was used to perform the separation  
 
with a mobile phase of 3% acetonitrile + 97% DI water + 0.1% TFA. The flow rate was  
 
1.0mL/min. The components were separated and collected as five fractions as Fraction A 
 
at 2.5 min, Fraction B at 3.0min, Fraction C at between 3.5min and 4.0min, Fraction D at  
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between 4.5min and 5.0min and Fraction E at between 9min and 12min. These five  
 
fractions were analyzed by the UPLC-MS MS (UPLC: Waters “Acuity Ultra Performance  
 
LC” with Waters C18 Column of 3.6×50mm; MS: Thermo TSQ Quantum Access – Triple  
 
Stage Quadruple Mass Spectrometer) to identify the fraction with the most abundant  
 
NAPQI-GSH conjugate. The UPLC-MS in this step had the same parameters as used for  
 
identification of the major stock for synthesized NAPQI-GSH conjugate. This series of  
 
analysis was done for obtaining the HPLC fraction with the most abundant NAPQI-GSH  
 
content to be used as a standard for the assays in which NAPQI-GSH was the product of  
 
the reaction. The molecular mass of the target peak of ionized NAPQI-GSH was 457.14  
 
amu. 
 
 II. H. iii. Setup of Enzyme Assay to Generate NAPQI-GSH 
 
Each aliquot of reaction was 200µL with 0.1M sodium phosphate buffer with a pH  
 
of 7.0. The enzyme sources were purified human liver 2E1 and human liver cytosol  
 
(as source of glutathione-S-transferase). The concentration of 2E1 was 13.2µM and the 
 
cytosol used was 40µL in 200µL reaction mixture. As substrates, 4-acetominophenol was 
 
added at 2mM and reduced glutathione was added at2mM. Such high concentrations of  
 
the enzymes and the substrates were used to get a high-enough yield of target  
 
NAPQI-GSH conjugate so as to get a signal response that was high enough. For the  
 
reactions of positive trials, 1.0mM NADPH was added to start the reactions. In the group  
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of negative control, no NADPH was added to make contrast. (Before starting the  
 
reactions, the reaction mixtures without NADPH were pre-incubated at 37˚C for 10min.)  
 
After NADPH was added, the reaction mixtures were homogenized by vortex and  
 
incubated at 37˚C for 60min before being quenched with 200µL acetonitrile. The liquids  
 
were centrifuged at 14,000rpm for 10min before for LC-MS analysis. The parameters for  
 
the LC-MS were the same as that for the identification of NAPQI-GSH conjugate from  
 
the synthesized crude material. 
 
 II. H. iv. Dose Response Assay of Purified Human Liver CYP2E1 with Ginger  
 
Hydrosol 
 
The total volume for each reaction was 200µLwith 0.1M sodium phosphate buffer  
 
with a pH of 7.0. Each reaction mixture had human liver CYP2E1 2.7nM together with  
 
human liver cytosol with a concentration of 5% of its original concentration as the source  
 
for glutathione-S-transferase. Reduced glutathione 2mM was used for all the reactions  
 
mixtures. The other substrate, acetaminophen, was tested at the concentration of800μM,  
 
which was close to the reported toxic concentration 1000μM [29]. NADPH was added to  
 
start the reactions. Brazilian ginger hydrosol was added at 12.5%, 25.0% and 50.0%. The  
 
peak for the protonated NAPQI-GSH with a molecular mass of around 457.14 amu  
 
appeared between 1.6 min and 2.2 min. The probable isomer of NAPQI-GSH conjugate  
 
was eluted between 0.6 min and 0.7 min. The peaks of the product (including the  
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isomerized product) were integrated and the dose response of the ginger hydrosol was  
 
measured as percent decrease of the product peaks. The dose responses were expressed in  
 
percentage of enzyme activity measured in peak areas of HPLC signal. Standard  
 
deviations were calculated. 
 
II. I. Michaelis-Menten Kinetic Analysis of Rabbit Liver CYP2E1 with Ginger  
 
 Extracts or Citral 
 
The set-up and components of the reaction mixtures for Michaelis-Menten kinetic  
 
analysis for rabbit liver CYP2E1 were the same as that of human liver CYP2E1. The  
 
method for calculation of inhibitory constants was also the same. The only difference was  
 
that citral was added with three different ratios of isomers. Citral was tested at three  
 
isomer ratios. They were neral: geranial=1:1.27, neral: geranial=1:1.45, 
 
neral: geranial=1:1.8. 
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CHAPTER III 
 
RESULTS AND DISCUSSION 
 
 
III. A. Production of Ginger Extracts 
 
The normal yield of the essential oil from ginger rhizome was about 2000 µL  
 
essential oil/ 500g ginger rhizomes. The ginger roots were frozen before being sliced for  
 
the convenience of processing. To prevent from loss of volatile constituents (observed as  
 
former dense smell of ginger in diffusing in the dryer box) and oxidation (observed as  
 
increased yellowish hue once compared with oil samples of the same source extracted  
 
without heated drying), the dehydration procedure was abandoned in order to procure the  
 
original volatile constituents of the ginger. 
 
III. B. Dose Responses of CYP450 with Ginger Extracts 
 
The dose response tests were done to assess the inhibitory effects of ginger  
 
essential oil and ginger hydrosol to the activities of the two isoforms of CYP450  
 
enzymes: 2E1 and 2A6. The results were expressed in the remaining activities of enzyme  
 
with presence a series of different concentrations of ginger essential oil or hydrosol. 
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III. B. i. Dose Responses of CYP2E1 with Ginger Extracts 
 
In comparison, both ginger essential oil and ginger hydrosol exhibited dose  
 
dependent inhibition on rabbit liver CYP2E1. For example, at the dose of 18 mg/L Costa  
 
Rican ginger essential oil, around 37.0% inhibition of activity was observed. At the dose  
 
of 18 mg/L Brazilian ginger essential oil, around 43.4% inhibition of activity was  
 
observed. At the dose of 12.5% of Costa Rican ginger hydrosols, around 66.2% inhibition  
 
of activity was observed. At the dose of 12.5% of Brazilian ginger hydrosol, around  
 
65.5% inhibition of activity was observed (Figure 3. 1). Adding the ginger hydrosol had  
 
stronger inhibition to rabbit liver CYP2E1 than adding the same volume of 18mg/L  
 
aqueous solution of ginger essential oil. In comparison, the inhibition of ginger extracts  
 
on human liver CYP2E1 complied well with that on rabbit liver CYP2E1, with both  
 
ginger essential oil and ginger hydrosol showing dose dependent inhibition. For example,  
 
at the dose of 12 mg/L Costa Rican ginger essential oil, around 18.3% inhibition of  
 
activity was observed. At the dose of 12 mg/L Brazilian ginger essential oil, around 
 
22.8% inhibition of activity was observed. At the dose of 12.5% of Costa Rican ginger  
 
hydrosol, around 44.8% inhibition of activity was observed. At the dose of 12.5% of  
 
Brazilian ginger hydrosol, around 60.0% inhibition of ginger hydrosol was observed.  
 
The hydrosol was also shown to give more prominent inhibition in enzyme assay of  
 
human liver CYP2E1 (Figure 3. 2). 
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A                              B 
 
 
C                              D 
 
Figure 3. 1. Dose Responses of Rabbit Liver CYP2E1 to Ginger Extracts.  A. Costa Rican ginger 
essential oil; B. Brazilian ginger essential oil; C. Costa Rican Ginger Hydrosol D. Brazilian ginger 
hydrosol. 
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                A                                B 
 
               C                                D 
 
Figure 3. 2. Dose Responses of Human Liver CYP2E1 to Ginger Extracts.  A. Costa Rican ginger 
essential oil; B. Brazilian ginger essential oil; C. Costa Rican ginger hydrosol D. Brazilian ginger hydrosol. 
 
 
 III. B. ii. Effect of Ginger Extracts on CYP2A6 
 
In addition to CYP2E1, the ginger extracts were tested on CYP2A6 in order to  
 
determine the comparative effects of these two isoforms of CYP450 enzymes. In contrast  
 
to the dose responses of CYP2E1 to ginger extracts, the rabbit liver CYP2A6 showed  
 
poor dose responses to the presences of ginger essential oil (Figure 3. 3) and ginger  
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hydrosol (Figure 3. 4). These results implicated the same poor dose responses of human  
 
liver CYP2A6 to the ginger extracts. For example, at the dose of 50% Costa Rican ginger  
 
hydrosol, only around 16.3% inhibition of human liver CYP2A6 activity was observed.  
 
In contrast, at the dose of 50% Costa Rican ginger hydrosol, around 78.9% inhibition of  
 
activity of human liver CYP2E1 was observed (Figure 3. 2. C). Therefore, ginger  
 
extracts showed a more selective inhibition on CYP2E1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. 3. Dose Response Test of Rabbit Liver CYP2A6 to Costa Rican Ginger Hydrosol. Only very 
weak inhibition was observed.  
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Figure 3. 4. Dose Response Test of Rabbit Liver 2A6 Assay to Ginger Essential Oil. The result 
indicated poor inhibition by ginger essential oil on CYP2A6. 
 
 
III. C. Components of Ginger Extracts 
 
The components of the samples of ginger essential oil were identified via direct  
 
analysis using GC-MS. The component analysis of the ginger hydrosols was done by  
 
firstly trapping the components onto a C18 column of HPLC, then eluting these  
 
components into methanol and finally analyzing these dissolved components by GC-MS.  
 
The results were expressed in the first part as the GC chromatograms of the organic  
 
components constituting the ginger essential oils and hydrosols. The second part was the  
 
bar graphs of the identified components in which the height of the bar of each component  
 
was proportional to its peak area in the corresponding GC chromatogram.  
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III. C. i. Components of Ginger Essential Oils 
 
The components of ginger essential oils were shown in their GC-MS  
 
chromatograms together with bar graphs. For both samples of Costa Rican ginger  
 
essential oil and Brazilian ginger essential oil, there were five major peaks shown by the  
 
GC chromatograms shown by Figure 3. 5 and Figure 3. 6, respectively. The  
 
compositions of the two ginger essential oil samples were very similar. The  
 
chromatograms showed they both contained citral, which had two isomers of neral and  
 
geranial. The peak area percentages of neral and geranial for Brazilian ginger essential oil  
 
were 9.98% and 17.68%, whereas the percentages of neral and geranial for Costa Rican  
 
ginger essential oil were 5.50% and 9.21%. Both of the two essential oil samples  
 
contained camphene, of which the peak area percentages were 4.38% for Brazilian ginger  
 
essential oil and 9.42 for Costa Rican ginger essential oil. The data of the percentages of  
 
the components’ peak areas were shown in Figure 3. 7 and Figure 3. 8. 
 
 
 
 
Figure 3. 5. GC Chromatogram of Costa Rican Ginger Essential Oil. 
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Figure 3. 6. GC Chromatogram of Brazilian Ginger Essential Oil. 
 
 
 
 
Figure 3. 7. Components of Brazilian Ginger Essential Oil. DOAL: 3, 7-dimethyl-6-octenal; 
MNK: methyl nonyl ketone; M(DH)C:2-methyl-5-(1,5-dimethyl-4-hexenyl)-1,3-cyclohexadiene; 
M(MMH)C:1-methyl-4-(5-methyl-1-methylene-4-hexenyl)-(s)-cyclohexene 
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Figure 3. 8. Components of Costa Rican Ginger Essential Oil. 
1I4M:1-isopropyl-4-methylenebicyclohexane; (DH)MB: 1-(1,5-dimethyl-4-hexenyl)-4-methyl benzene; 
(DH)MC:5-(1,5-dimethyl-4-hexenyl)-2-methyl-1,3-cyclohexadiene; 
M(MMH)C: 1-methyl-4-(5-methyl-1-methylene-4-hexenyl)-cyclohexene; 
3(DH)MC:3-(1,5-dimethyl-4-hexenyl)-6-methylene-1-cyclohexene 
 
 
III. C. ii. Components of Ginger Hydrosols 
 
The components of ginger hydrosols were shown in their GC-MS chromatograms  
 
together with bar graphs. For both samples of Costa Rican ginger hydrosol and Brazilian  
 
ginger hydrosol, there were five peaks shown by the GC chromatograms shown by  
 
Figure 3. 9 and Figure 3. 10, respectively. The components of the two ginger hydrosol  
 
samples were very similar. The major components of ginger hydrosol (with a peak area  
 
taking up ≥10% of the chromatogram) were 2-heptanol, eucalyptol and citral (with two  
 
isomers of neral and geranial) as shown in Figure 3. 11 and Figure 3. 12. 
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Figure 3. 9. GC Chromatogram of Costa Rican Ginger Hydrosol. 
 
 
 
 
Figure 3. 10. GC Chromatogram of Brazilian Ginger Hydrosol. 
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Figure 3. 11. Components of Costa Rican Ginger Hydrosol. The components of the ginger hydrosol 
were determined to be 2-heptanol (9.16%), eucalyptol (17.24%), 3,7-dimethyl-1,6-octadien-3-ol (3.34%), 
isoborneol (7.52%), p-menth-1-en-8-ol (7.41%), neral (24.5%), geranial (37.5%), others (4.40%).  
 
 
 
 
Figure 3. 12. Components of Brazilian Ginger Hydrosol. The components of the ginger hydrosol were 
determined to be 2-heptanol (11.9%), eucalyptol (13.2%), borneol (3.8%), p-menth-1-en-8-ol (3.6%), 
β-citronellol (3.3%), neral (22.5%), geranial (34.0%), others (6.0%).  
9.16% 
17.24% 
3.34% 
7.52% 7.41% 
21.89% 
29.04% 
4.40% 
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
30.00%
35.00%
R
el
a
ti
v
e 
P
ea
k
 P
er
ce
n
ta
g
e 
Components 
Components of Organic Components of Brazilian Ginger 
Hydrosol 
11.90% 13.20% 
3.80% 3.60% 3.30% 
22.50% 
1.70% 
34.00% 
6.00% 
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
30.00%
35.00%
40.00%
R
el
a
ti
v
e 
P
ea
k
 P
er
ce
n
ta
g
e
 
Components 
Components of Organic Components of Brazilian Ginger Hydrosol 
43 
 
III. D. Dose Response Tests of CYP2E1 with Major Components from Ginger  
 
 Hydrosol 
 
Because eucalyptol was determined as a major component of ginger hydrosols  
 
(14.2% for Costa Rican ginger hydrosol and 13.2% for Brazilian ginger hydrosol), it was  
 
tested in dose response assays of CYP2E1. It only showed weak inhibition at very high  
 
concentrations (Figure 3. 13). Therefore, eucalyptol was excluded as an inhibitor from  
 
ginger hydrosol to CYP2E1. In contrast, citral showed significant dose dependent  
 
inhibition on human liver CYP2E1. Greater than 50% inhibition of activity was observed  
 
at 100 μM concentration (Figure 3. 14).These results implicated citral as the target  
 
inhibitor for the further studies.  
 
 
 
 
Figure 3. 13. Dose Response of Human Liver CYP2E1 to Eucalyptol. The dose dependent inhibition of 
eucalyptol on CYP2E1 was very weak. 
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Figure 3. 14. Dose Response Test of Human Liver CYP2E1 to Citral Standard (Neral: 
Geranial=1:1.8). Citral showed remarkable inhibition on CYP2E1 at a dose of 122μM. 
 
 
III. E. Standardization of Citral in Ginger Hydrosol 
 
Because citral was determined as a major inhibitor in ginger hydrosol, its  
 
concentrations were standardized. For the hydrosol of Costa Rican ginger hydrosol, the  
 
citral’s concentration was determined to be 965μM. For the hydrosol of Brazilian  
 
ginger, the citral’s concentration was determined to be 1259μM. For both of the ginger  
 
hydrosols, the isomer ratio of citral was neral: gereanial=1: 1.4. In order to assess the  
 
contribution of citral to ginger extracts, the citral concentrations in ginger essential oil  
 
solutions and ginger hydrosols were standardized. For the ginger hydrosols, the citral  
 
concentrations were in the range of 1.0 mM. For the ginger essential oil solutions with a  
 
concentration of 48 mg/L, the citral concentrations were in the range of 70 to 90 μM as 
 
shown in Table 3. 1. 
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Table 3. 1. Standardization of Citral in Ginger Essential Oil and Hydrosol. For ginger essential oils, the 
ratio of neral: geranial=1: 1.8. For ginger hydrosols, the ratio of neral: geranial=1: 1.4. The concentration of 
citral in the ginger extracts, i.e. ginger essential oil’s solution of 48mg/ L and original ginger hydrosol was 
standardized by HPLC (Shimazu LC20-AT). 
 
Ginger Extracts Citral 
Concentration 
Ratio of Neral: 
Geranial  
Costa Rican Ginger  
Hydrosol 
965μM 1: 1.4 
Brazilian Ginger Hydrosol 1259μM 1: 1.4 
Costa Rican Ginger Essential 
Oil Solution: 48mg/L 
73μM 1:1.8 
Brazilian Ginger Essential Oil 
Solution: 48mg/L 
91μM 1:1.8 
 
 
III. F. Preparation of Standard Citral Solution with Desired Isomer Ratio 
 
To prepare standard citral solution, dose response tests of CYP2E1 with organic  
 
solvents as mobile phases to elute citral were carried out to select the one with the  
 
weakest inhibitory potency to CYP2E1. For the selection of the organic mobile phase for  
 
isolation of citral standard, the results of dose dependence tests of human liver CYP2E1  
 
showed stronger inhibition by methanol under the same conditions of the dose  
 
dependence tests of CYP2E1 with ginger extracts (Figure 3. 15). Therefore, acetonitrile  
 
was selected as the non-polar mobile phase for isolating citral stock solution with an  
 
isomer ratio that was similar with the isomer ratio of citral in ginger hydrosol. The  
 
isolated citral solutions contained citral with a concentration high enough and could be  
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sufficiently diluted to decrease the concentration of acetonitrile to as low as 0.1% before  
 
used in assays of CYP2E1. Therefore, the undesired effect of acetonitrile was removed.  
 
One fraction of isolated citral solution contained an isomer ratio of neral:  
 
geranial=1:1.27; it showed ~70% inhibition at 0.2mM to the purified human liver 2E1  
 
(Figure 3. 16). This dose response complied well with the results of human liver  
 
CYP2E1 in the S9 extract from human liver. It was noticed that the doses of enzyme  
 
administered did not affect the IC50 value of the purified CYP2E1 when citral was added  
 
as the 2E1 inhibitor, though the enzyme sources administered with a higher dose did  
 
show higher catalytic activities.  
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                  A 
 
 
                   B 
 
Figure 3. 15. Dose Responses of Human Liver CYP2E1 to Acetonitrile and Methanol. A. Dose 
Response to Acetonitrile; B. Dose Response to Methanol. 
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Figure 3. 16. Dose Response of Purified Human Liver CYP2E1 to Citral (Neral: Geranial=1:1.27). 
For each reaction, 42.5μM CYP450 was used. 
 
 
III. G. Michaelis-Menten Kinetics of Human Liver CYP2E1 with Citral or Ginger  
 
 Extracts 
 
Michaelsis-Menten kinetic analysis of human liver CYP2E1 was carried out with  
 
or without presence of the inhibitors, i. e. citral or ginger extracts. The values (expressed  
 
with standard deviations) of KM and Vmax were shown in the curves of the enzyme  
 
without presence of inhibitors. The KM
app
, Vmax
app
 values (expressed with standard  
 
deviations) were shown in the curves with presence of the inhibitors. The curves were  
 
shown with the doses of inhibitor added in the corresponding reactions. The results  
 
showed that citral (Neral: Geranial=1:1.27) was a competitive inhibitor to human liver  
 
CYP2E1 with an inhibitory constant KI of 43.0µM. In comparison, both the ginger  
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competitive inhibition, the inhibitory constant KI was calculated with the equation of  
 
KI=KM*[I]/ (KM
app
-KM); for the non-competitive inhibition, the inhibitory constant KI’  
 
was calculated with the equation of KI’=[I]*Vmax
app
/ (Vmax-Vmax
app
). For the Brazilian  
 
ginger essential oil, its competitive inhibitory constant was 27.3mg/L: 
 
 
KI= KM*[I]/ (KM
app
-KM)=18.4mg/L*70.5 µM /(118.2 µM -70.5 µM)= 27.3mg/L. 
 
 
 The competitive inhibitory constant for Costa Rican ginger essential oil was  
 
calculated to be KI=29.9mg/L. Meanwhile, the Brazilian ginger hydrosol showed a KI  
 
that corresponding to 4.6% of its original concentration. Such a dose of hydrosol would  
 
contain 45.5 µM citral (neral: geranial=1:1.4) as referred to the standardized citral  
 
concentrations ginger hydrosols: 4.6% Brazilian ginger hydrosol=4.6%*1259µM  
 
citral=45.5µM citral. The KI for the Brazilian ginger hydrosol was 3.6% of its original  
 
concentration. At this concentration, the citral’s content was 44.3µM (neral:  
 
geranial=1:1.4). These data above were shown in Figure 3. 17 and Table 3. 2. These  
 
citral concentrations that correlated with Costa Rican ginger hydrosol’s KI and Brazilian  
 
ginger hydrosol’s KIin human liver CYP2E1 inhibition were very similar with the KI of  
 
pure citral with a similar isomer proportion in the inhibition of the same human liver  
 
CYP2E1. This close similarity implicated that citral was the predominant CYP2E1  
 
component in these ginger hydrosols. 
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Prior researches had shown citral as an inhibitor to other species of CYP450. For  
 
example, citral was shown by Raner et al as an inhibitor of CYP1A2 [30] and by Seo et al  
 
as an inhibitor of CYP2B6 [31] 
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                 A                                B 
 
 
                 C                                D 
 
Figure 3. 17. Michaelis-Menten Curves of Human Liver CYP2E1 with Ginger Extracts. 
A. Michaelis-Mentencurve with Brazilian ginger essential oil. B. Michaelis-Mentencurve with Costa Rican 
ginger hydrosol. C. Michaelis-Mentencurve with Citral (neral: geranial=1:1.27). D. Michaelis-Mentencurve 
with Brazilian Ginger Hydrosol. 
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Table 3. 2. Michaelis-Menten Kinetics of Human Liver CYP2E1 with Ginger Extracts and Citral 
Standard (Neral: Geranial=1:1.27). 
 
Inhibitor Neral: Geranial Type of Inhibition Inhibitory 
Constant 
 Citral  1:1.27 Competitive  43.0µM 
Brazilian 
Ginger 
Essential Oil 
1:1.8 Competitive  27.3mg/L 
Costa Rican 
Ginger 
Essential Oil 
1:1.8 Competitive 21.9mg/L 
Brazilian 
Ginger 
Hydrosol 
 
1:1.4 
 
Competitive 
3.6% of Original 
Concentration 
(45.5µM citral) 
Costa Rican 
Ginger 
Hydrosol 
 
1:1.4 
 
Competitive 
 
4.6% of Original 
Concentration 
(44.3 µM citral) 
 
 
III. H. Inhibition of Human 2E1 by Ginger Hydrosol in Acetaminophen Metabolism 
 
The synthesized standard of NAPQI-GSH was further isolated from the crude  
 
product of synthesized and the time for it to be eluted in the UPLC-MS chromatogram  
 
was determined. With the reference provided by the NAPQI-GSH standard, the peak and  
 
the time for elution of the NAPQI-GSH formed from catalytic reaction were determined.  
 
Ultimately, the inhibitory potency of ginger hydrosol to the activity of human liver  
 
CYP2E1 was determined. 
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III. H. i. Identification of the Stock of Synthesized NAPQI-Glutathione  
 
Complex 
 
The LC-MS chromatograms showed that the component analysis of the two  
 
residues collected from the synthesis of NAPQI-GSH conjugate. From the peak area  
 
values (Figure 3. 18), the concentration of NAPQI-GSH in the residue solution from the  
 
evaporation of methanol was much higher than the concentration of NAPQI-GSH in the  
 
residue solution from the methanol extraction. At the same mass concentrations of  
 
15 g/ L, the aqueous solution of the solid residue collected from condensation by  
 
methanol evaporation showed a signal peak of NAPQI-GSH with an area 76 times more  
 
than the peak area for the solution of residue from methanol extraction. Therefore, stock  
 
solution of this residue from condensation by methanol evaporation was used as the  
 
source for isolating the standard of NAPQI-GSH conjugate to detect the NAPQI-GSH  
 
formation in the assays in which the formation of NAPQI-GSH was catalyzed by  
 
CYP2E1 and glutathione-S-transferase contained by the human liver cytosol. 
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Figure 3. 18. The UPLC Chromatograms of Two Residues from the Synthesis of NAPQI-Glutathione. 
A. The target peak of NAPQI-GSH shown in the selected ion chromatograms for the residue from the 
methanol extraction of the crude synthesized NAPQI-GSH, B. the target peak of NAPQI-GSH shown as 
the selected mass for the residue from the evaporation of methanol from the crude synthesized 
NAPQI-GSH.  
 
 
III. H. ii. Test of Isolated Standard NAPQI-GSH Complex from the Stock 
 
The LC-MS chromatograms of the base peaks (without selection of a certain mass)  
 
implicated the most probable target peak for the NAPQI-GSH conjugate was more  
 
abundant in HPLC Fraction. C. (Fig. III. 19. C) The target peak of NAPQI-GSH was  
 
shown in the chromatogram at between 1.6 min and 2.2min, with a molecular mass of  
A 
B 
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about 457.14 amu. Fraction. C was thus stored and used as standard of NAPQI-GSH. 
 
 
 
 
Figure 3. 19. LC-MS Chromatograms of Five Fractions of HPLC Separation Products of Stock 
Solution Containing NAPQI-GSH Conjugate. A. The fraction obtained from eluent at 2.5min; B. The 
fraction obtained from eluent at 3.0min; C. The fraction obtained from eluent from 3.5min to 4.0min; D. 
The fraction obtained from eluent from4.5min to 5.0min; E. The fraction obtained from eluent from 9.0 
min to 12.0min. 
 
 
III. H. iii. Detection of NAPQI-GSH in Enzyme Assay 
 
The target peaks of the ionized NAPQI-GSH and its isomer showed a molecular  
 
mass of around 457.14 amu. For the samples of the positive trials to which NADPH was  
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min and 0.7 min and at between 1.6 min and 2.2 min (Fig. III. 20. C, D). In contrast, for  
 
the chromatograms of the negative controls (Fig. III. 20. A,B), there were no peaks that  
 
appeared at these two times. 
 
 
 
 
Figure 3. 20. LC-MS Chromatograms of Detection of NAPQI-GSH Formation. The formation of the 
complex was catalyzed by CYP2E1 and glutathione-S-Transferase from Human Liver Cytosol. A, B: the 
negative controls without adding NADPH; C, D: the positive trials with presence of NADPH. For the 
positive trials, there were two peaks of the target NAPQI-GSH which were eluted between 0.6 min and 0.7 
min and between 1.6 min and 2.2 min. 
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III. H. iv. Inhibition of Purified Human Liver 2E1 by Ginger Hydrosol in  
 
 Metabolism of Acetaminophen 
 
The metabolism of acetaminophen by purified human liver 2E1 was shown to be  
 
inhibited by Brazilian ginger hydrosol when acetaminophen was added at the dose of  
 
800µM. As shown in Figure 3. 21, the inhibition of human liver became stronger as the  
 
dose of Brazilian ginger hydrosol was increased. With the presence of ginger hydrosol at  
 
the concentration of 25%, a close to 50% inhibition in the enzyme activity in  
 
acetaminophen metabolism was observed. This concentration of Brazilian ginger  
 
hydrosol corresponds to a dose of citral of around 158 μM. 
 
 
 
 
Figure 3. 21. Dose Responses of Purified Human Liver 2E1 to Brazilian Ginger Hydrosol in 
Acetaminophen Metabolism. The dose of acetaminophen as CYP2E1 substrate was 800 μM. 
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III. I. Michaelis-Menten Kinetics of Rabbit Liver CYP2E1 with Ginger Extracts and  
 
 Citral 
 
The Michaelsis-Menten kinetic analysis of rabbit liver was carried out with  
 
presence of ginger hydrosols, ginger essential oils and citral with three different isomer  
 
ratios. The purpose was to determine the types of inhibition (competitive, non- 
 
competitive or mixed) and the corresponding inhibitory constants. For the competitive  
 
inhibition, the inhibitory constant KI was calculated with the equation of KI=KM*[I]/  
 
(KM
app
-KM); for the non-competitive inhibition, the inhibitory constant KI’ was calculated  
 
with the equation of KI’=[I]*Vmax
app
/ (Vmax-Vmax
app
). For the rabbit liver CYP2E1, the  
 
ginger essential oils were determined to be competitive inhibitors. The inhibitory constant  
 
for Brazilian ginger essential oil was  
 
 
KI’=[I]*Vmax
app
/(Vmax-Vmax
app
)=(19.2mg/L*68.4%)/(100.0%-68.4%=41.6mg/L.  
 
 
 The constant for the Costa Rican ginger essential oil was calculated as  
 
KI’=62.2mg/L (Figure 3. 22 and Table 3. 3).  
 
In comparison, the ginger hydrosols were determined to have mixed inhibition to  
 
the rabbit liver CYP2E1 and they have both a competitive inhibitory constant and a non- 
 
competitive inhibitory constant. For example, the competitive inhibitory constant for the  
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Brazilian ginger hydrosol was calculated 6.3% of its original concentration, which  
 
corresponded to 78.7μM citral: 
 
 
KI=KM*[I]/(KM
app
-KM)=(74.1µM*7.5%)/(163.0µM-74.1µM)=6.3%.  
 
 
Its non-competitive inhibitory constant was 11.7% of its original concentration, which  
 
corresponded to 112.9μM citral (Figure 3. 22 and Table 3. 3). 
 
For rabbit liver CYP2E1 added with citral, it seemed that a shift in the neral:  
 
geranial proportion could cause a shift in the Michaelis-Menten kinetics of rabbit liver  
 
CYP2E1. At a relatively higher neral to geranial proportion like 1:1.27, citral exerted  
 
non-competitive inhibition on the rabbit liver CYP2E1 with KI=166μM. When the ratio  
 
of geranial was increased to a adequately high value like neral: geranial=1:1.8, the  
 
inhibition of the rabbit liver CYP2E1 by citral turned out to be competitive with  
 
KI=83μM. Noticeably, once the neral to geranial ratio was selected as a value in between,  
 
say, 1: 1.47, the inhibition of the rabbit liver CYP2E1 by citral became a mixed inhibition  
 
with the competitive constant KI=140μM and the non-competitive KI’=487μM (Figure 3.  
 
23 and Table 3. 2). Therefore, it seemed that an increase of geranial proportion in citral  
 
from a higher neral to geranial ratio could shift the citral from a non-competitive inhibitor  
 
to a competitive inhibitor to the rabbit liver CYP2E1. 
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Figure 3. 22. Michaelis-Menten Curves of Rabbit Liver CYP2E1 with Ginger Extracts. A. Costa Rican 
ginger essential oil. B. Brazilian ginger essential oil. C. Costa Rican ginger hydrosol. D. Brazilian ginger 
hydrosol. 
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Figure 3. 23. Michaelis-Menten Curves of Rabbit Liver CYP2E1 with Citral. A. Citral (neral: geranial= 
1: 1.27). B. Citral (neral: geranial= 1: 1.8). C. Citral (neral: geranial= 1: 1.47). 
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Table 3. 3. Michaelis-Menten Kinetics of Rabbit Liver CYP2E1 with Ginger Extracts and Citral 
Standards. 
 
Inhibitor Neral: Geranial Inhibition Type & Ki 
 
Costa Rican Ginger 
Essential Oil  
 
 
1:1.8 
 
Non-Competitive KI=62.2mg/L 
 
Brazilian Ginger 
Essential Oil 
 
 
 
 
1:1.8 
 
 
Non-Competitive KI=41.6mg/L 
 
Costa Rican Ginger 
Hydrosol 
 
 
1:1.4 
Mixed Inhibition; 
Non-Competitive KI=10% hydrosol 
(96.5μM citral) 
 Competitive KI’=11.7% hydrosol 
(112.9μM citral) 
 
 
Brazilian Ginger 
Hydrosol 
 
 
1:1.4 
Mixed Inhibition; 
Competitive KI=6.3% hydrosol 
(78.7μM citral) 
Non-Competitive KI’=6.3% 
hydrosol (79.31μM citral) 
Citral 1:1.27 Non-Competitive 
KI=166μM 
Citral 1:1.8 Competitive 
KI=83μM. 
 
Citral 
 
1:1.47 
Mixed inhibition; 
Competitive KI=140μM 
Non-Competitive KI’=487μM 
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CHAPTER IV 
 
CONCLUSION
 
 
Ginger extracts, no matter essential oil or hydrosol, were determined to be  
 
inhibitors of cytochrome 450 2E1. Ginger extracts made from steam distillation exerted  
 
significant inhibitions on CYP2E1 but poor inhibition on CYP2A6. Ciral was finally  
 
identified as the predominant human liver 2E1 inhibitor presenting in ginger hydrosol  
 
from the Michaelis-Menten kinetic analysis. Citral also demonstrated inhibition on  
 
metabolism of acetaminophen by human liver 2E1 into NAPQI. Therefore, citral might  
 
be used to physiologically provide with natural prevention of human liver toxicity via  
 
inhibition of liver CYP2E1 in generating NAPQI from metabolism of acetaminophen.  
 
However, to finally verify the possible clinical value of citral in this scenario, further  
 
evidence is still needed from in vitro cell assays and in vivo assays. The probable future  
 
test could be carried out by assay of 2E1 over-expressed HepG2 cells with presence of  
 
citral. 
 
The Michaelsis-Menten kinetics of rabbit liver CYP2E1 was a branch research of  
 
this project. For the rabbit liver CYP2E1, ginger extracts and citral had shown more  
 
diverse inhibitory kinetics. Moreover, an increase of geranial proportion in citral from a  
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higher neral to geranial ratio could shift citral’ inhibitory kinetics on the rabbit liver 
 
CYP2E1. 
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